| abstract |
The present invention relates to a novel heterotricyclic derivative compound and use thereof, and more particularly, to a novel heterotricyclic derivative having inhibitory activity of EZH1 (Enhancer of zeste homolog 1) and/or EZH2 (Enhancer of zeste homolog 2) activity. It relates to a click derivative compound, a pharmacologically acceptable salt thereof, or a pharmaceutical composition comprising such a compound. |